3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
188
Leukemia, Lymphocytic, Chronic, B-Cell
69
Myelodysplastic Syndromes
47
Recurrence
30
Leukemia
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, Mantle-Cell
20
Leukemia, Myelomonocytic, Chronic
19
Hematologic Neoplasms
14
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Non-Hodgkin
13
Lymphoma
13
Leukemia, Biphenotypic, Acute
13
Burkitt Lymphoma
13
Lymphoma, B-Cell, Marginal Zone
12
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
11
Neoplasms
10
Waldenstrom Macroglobulinemia
8
Myeloproliferative Disorders
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
7
Neoplasm, Residual
6
Leukemia, Myeloid
5
Blastic Plasmacytoid Dendritic Cell Neoplasm
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
GATA2 Deficiency
4
Leukemia, Monocytic, Acute
3
Immunoglobulin Light-chain Amyloidosis
3
Interventions
regorafenib
2
ivosidenib
2
Proton Therapy
2
enasidenib
1
durvalumab
1
capivasertib
1
abemaciclib
1
Zoledronic Acid
1
Weight-Bearing
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Range of Motion, Articular
1
Pharmacogenomic Testing
1
Paclitaxel
1
Immunoglobulin G
1
HhAntag691
1
Gemcitabine
1
Disulfides
1
Cisplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Chondrosarcoma
×
venetoclax
×
1 year
×
Clear all
No trials found.